Skip to main content
Erschienen in: Annals of Surgical Oncology 2/2020

09.08.2019 | Breast Oncology

Use of Mammographic Measurements to Predict Complications After Nipple-Sparing Mastectomy in BRCA Mutation Carriers

verfasst von: Ko Un Park, MD, Anna Weiss, MD, Kelly Rosso, MD, Min Yi, MD, PhD, Kelly Hunt, MD, Henry Kuerer, MD, PhD, Summer E. Hanson, MD, Rosalind Candelaria, MD, Sarah Tevis, MD, Alastair Thompson, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

There is limited data evaluating mastectomy skin flap complications of nipple-sparing mastectomy (NSM) in patients with BRCA gene mutations. The purpose of this study was to identify factors associated with post-operative complications in BRCA mutation carriers undergoing NSM.

Methods

Following institutional review board approval, we interrogated a prospectively collected institutional database for patients undergoing NSM who tested positive for BRCA1/2 mutations. Patient characteristics, preoperative details, and complications were evaluated. Digital mammogram was used to estimate the breast volume.

Results

From August 2009 to December 2017, 59 patients (2 males) with BRCA1/2 mutations underwent 114 NSMs. Ninety-two (80%) were risk-reduction surgeries. Thirty-two (28%) underwent single-stage reconstruction (24 autologous). The overall complication rate was 26.3% (N = 30), and 10.5% (N = 12) underwent unanticipated reoperation. 8.8% (N = 10) had full-thickness skin flap necrosis, 10.5% (N = 12) nipple necrosis, and 4.4% (N = 5) full-thickness nipple necrosis. These complications were associated with larger breast volume (799.4 cc vs. 544.1 cc, p < 0.001) and greater body mass index (27.8 vs. 24.3, p < 0.001). By univariate analysis, body mass index and breast volume greater than 675 cc were associated with significantly higher complication rate (odds ratios 1.2 and 4.5 respectively, p = 0.001).

Conclusions

This study confirms that NSM in BRCA1/2 mutation carriers is associated with complications in one in four patients. Utilizing the preoperative mammograms to estimate breast size may be more helpful than breast cup size in counseling preoperatively the risks of complications.
Literatur
2.
Zurück zum Zitat Smith BL, Tang R, Rai U, et al. Oncologic safety of nipple-sparing mastectomy in women with breast cancer. J Am Coll Surg. 2017;225:361–5.CrossRef Smith BL, Tang R, Rai U, et al. Oncologic safety of nipple-sparing mastectomy in women with breast cancer. J Am Coll Surg. 2017;225:361–5.CrossRef
3.
Zurück zum Zitat Wei CH, Scott AM, Price AN, et al. Psychosocial and sexual well-being following nipple-sparing mastectomy and reconstruction. Breast J. 2016;22:10–7.CrossRef Wei CH, Scott AM, Price AN, et al. Psychosocial and sexual well-being following nipple-sparing mastectomy and reconstruction. Breast J. 2016;22:10–7.CrossRef
4.
Zurück zum Zitat Djohan R, Gage E, Gatherwright J, et al. Patient satisfaction following nipple-sparing mastectomy and immediate breast reconstruction: an 8-year outcome study. Plast Reconstr Surg. 2010;125:818–29.CrossRef Djohan R, Gage E, Gatherwright J, et al. Patient satisfaction following nipple-sparing mastectomy and immediate breast reconstruction: an 8-year outcome study. Plast Reconstr Surg. 2010;125:818–29.CrossRef
5.
Zurück zum Zitat Peled AW, Duralde E, Foster RD, et al. Patient-reported outcomes and satisfaction after total skin-sparing mastectomy and immediate expander-implant reconstruction. Ann Plast Surg. 2014;72 Suppl 1:S48–52.PubMed Peled AW, Duralde E, Foster RD, et al. Patient-reported outcomes and satisfaction after total skin-sparing mastectomy and immediate expander-implant reconstruction. Ann Plast Surg. 2014;72 Suppl 1:S48–52.PubMed
6.
Zurück zum Zitat Yoon-Flannery K, DeStefano LM, De La Cruz LM, et al. Quality of life and sexual well-being after nipple sparing mastectomy: a matched comparison of patients using the breast Q. J Surg Oncol. 2018;118:238–42.CrossRef Yoon-Flannery K, DeStefano LM, De La Cruz LM, et al. Quality of life and sexual well-being after nipple sparing mastectomy: a matched comparison of patients using the breast Q. J Surg Oncol. 2018;118:238–42.CrossRef
7.
Zurück zum Zitat Jakub JW, Peled AW, Gray RJ, et al. Oncologic safety of prophylactic nipple-sparing mastectomy in a population with BRCA mutations: a multi-institutional study. JAMA Surg. 2018;153:123–9.CrossRef Jakub JW, Peled AW, Gray RJ, et al. Oncologic safety of prophylactic nipple-sparing mastectomy in a population with BRCA mutations: a multi-institutional study. JAMA Surg. 2018;153:123–9.CrossRef
8.
Zurück zum Zitat Yao K, Liederbach E, Tang R, et al. Nipple-sparing mastectomy in BRCA1/2 mutation carriers: an interim analysis and review of the literature. Ann Surg Oncol. 2015;22:370–6.CrossRef Yao K, Liederbach E, Tang R, et al. Nipple-sparing mastectomy in BRCA1/2 mutation carriers: an interim analysis and review of the literature. Ann Surg Oncol. 2015;22:370–6.CrossRef
9.
Zurück zum Zitat Sakurai T, Zhang N, Suzuma T, et al. Long-term follow-up of nipple-sparing mastectomy without radiotherapy: a single center study at a Japanese institution. Med Oncol. 2013;30:481.CrossRef Sakurai T, Zhang N, Suzuma T, et al. Long-term follow-up of nipple-sparing mastectomy without radiotherapy: a single center study at a Japanese institution. Med Oncol. 2013;30:481.CrossRef
10.
Zurück zum Zitat Park KU, Nathanson D. Translating the 2-dimensional mammogram into a 3-dimensional breast: Identifying factors that influence the movement of pre-operatively placed wire. J Surg Oncol. 2017;116:208–12.CrossRef Park KU, Nathanson D. Translating the 2-dimensional mammogram into a 3-dimensional breast: Identifying factors that influence the movement of pre-operatively placed wire. J Surg Oncol. 2017;116:208–12.CrossRef
11.
Zurück zum Zitat Gould DJ, Hunt KK, Liu J, et al. Impact of surgical techniques, biomaterials, and patient variables on rate of nipple necrosis after nipple-sparing mastectomy. Plast Reconstr Surg. 2013;132:330e–8e.CrossRef Gould DJ, Hunt KK, Liu J, et al. Impact of surgical techniques, biomaterials, and patient variables on rate of nipple necrosis after nipple-sparing mastectomy. Plast Reconstr Surg. 2013;132:330e–8e.CrossRef
12.
Zurück zum Zitat Algaithy ZK, Petit JY, Lohsiriwat V, et al. Nipple sparing mastectomy: Can we predict the factors predisposing to necrosis? Eur J Surg Oncol (EJSO). 2012;38:125–9.CrossRef Algaithy ZK, Petit JY, Lohsiriwat V, et al. Nipple sparing mastectomy: Can we predict the factors predisposing to necrosis? Eur J Surg Oncol (EJSO). 2012;38:125–9.CrossRef
13.
Zurück zum Zitat Ahn SJ, Woo TY, Lee DW, et al. Nipple-areolar complex ischemia and necrosis in nipple-sparing mastectomy. Eur J Surg Oncol. 2018;44:1170–6.CrossRef Ahn SJ, Woo TY, Lee DW, et al. Nipple-areolar complex ischemia and necrosis in nipple-sparing mastectomy. Eur J Surg Oncol. 2018;44:1170–6.CrossRef
14.
Zurück zum Zitat De Vita R, Zoccali G, Buccheri EM, et al. Outcome evaluation after 2023 nipple-sparing mastectomies: our experience. Plas Reconstr Surg. 2017;139:345e–7e. De Vita R, Zoccali G, Buccheri EM, et al. Outcome evaluation after 2023 nipple-sparing mastectomies: our experience. Plas Reconstr Surg. 2017;139:345e–7e.
15.
Zurück zum Zitat Colwell AS, Tessler O, Lin AM, et al. Breast reconstruction following nipple-sparing mastectomy: predictors of complications, reconstruction outcomes, and 5-year trends. Plast Reconstr Surg. 2014;133:496–506.CrossRef Colwell AS, Tessler O, Lin AM, et al. Breast reconstruction following nipple-sparing mastectomy: predictors of complications, reconstruction outcomes, and 5-year trends. Plast Reconstr Surg. 2014;133:496–506.CrossRef
17.
Zurück zum Zitat Frey JD, Salibian AA, Karp NS, Choi M. The impact of mastectomy weight on reconstructive trends and outcomes in nipple-sparing mastectomy: progressively greater complications with larger breast size. Plast Reconstr Srug Global Open. 2018;141:795e–804e.CrossRef Frey JD, Salibian AA, Karp NS, Choi M. The impact of mastectomy weight on reconstructive trends and outcomes in nipple-sparing mastectomy: progressively greater complications with larger breast size. Plast Reconstr Srug Global Open. 2018;141:795e–804e.CrossRef
18.
Zurück zum Zitat Choppin SB, Wheat JS, Gee M, Goyal A. The accuracy of breast volume measurement methods: a systematic review. Breast. 2016;28:121–9.CrossRef Choppin SB, Wheat JS, Gee M, Goyal A. The accuracy of breast volume measurement methods: a systematic review. Breast. 2016;28:121–9.CrossRef
19.
Zurück zum Zitat Bengtson BP, Glicksman CA. The standardization of bra cup measurements: redefining bra sizing language. Clin Plast Surg. 2015;42:405–11.CrossRef Bengtson BP, Glicksman CA. The standardization of bra cup measurements: redefining bra sizing language. Clin Plast Surg. 2015;42:405–11.CrossRef
20.
Zurück zum Zitat Yoo A, Minn KW, Jin US. Magnetic resonance imaging-based volumetric analysis and its relationship to actual breast weight. Arch Plast Surg. 2013;40:203–8.CrossRef Yoo A, Minn KW, Jin US. Magnetic resonance imaging-based volumetric analysis and its relationship to actual breast weight. Arch Plast Surg. 2013;40:203–8.CrossRef
21.
Zurück zum Zitat Kalbhen CL, McGill JJ, Fendley PM, et al. Mammographic determination of breast volume: comparing different methods. Am J Roentgenol. 1999;173:1643–9.CrossRef Kalbhen CL, McGill JJ, Fendley PM, et al. Mammographic determination of breast volume: comparing different methods. Am J Roentgenol. 1999;173:1643–9.CrossRef
22.
Zurück zum Zitat Breast Cancer Risk Reduction. NCCN Guidelines 2018; Version 2.2018. Breast Cancer Risk Reduction. NCCN Guidelines 2018; Version 2.2018.
23.
Zurück zum Zitat Selber JC, Wren JH, Garvey PB, et al. Critical evaluation of risk factors and early complications in 564 consecutive two-stage implant-based breast reconstructions using acellular dermal matrix at a single center. Plast Reconstr Surg. 2015;136:10–20.CrossRef Selber JC, Wren JH, Garvey PB, et al. Critical evaluation of risk factors and early complications in 564 consecutive two-stage implant-based breast reconstructions using acellular dermal matrix at a single center. Plast Reconstr Surg. 2015;136:10–20.CrossRef
24.
Zurück zum Zitat Krajewski AC, Boughey JC, Degnim AC, et al. Expanded indications and improved outcomes for nipple-sparing mastectomy over time. Ann Surg Oncol. 2015;22:3317–23.CrossRef Krajewski AC, Boughey JC, Degnim AC, et al. Expanded indications and improved outcomes for nipple-sparing mastectomy over time. Ann Surg Oncol. 2015;22:3317–23.CrossRef
25.
Zurück zum Zitat Diep GK, Hui JYC, Marmor S, et al. Postmastectomy reconstruction outcomes after intraoperative evaluation with indocyanine green angiography versus clinical assessment. Ann Surg Oncol. 2016;23:4080–5.CrossRef Diep GK, Hui JYC, Marmor S, et al. Postmastectomy reconstruction outcomes after intraoperative evaluation with indocyanine green angiography versus clinical assessment. Ann Surg Oncol. 2016;23:4080–5.CrossRef
26.
Zurück zum Zitat Newman MI, Jack MC, Samson MC. SPY-Q analysis toolkit values potentially predict mastectomy flap necrosis. Ann Plast Surg. 2013;70:595–8.CrossRef Newman MI, Jack MC, Samson MC. SPY-Q analysis toolkit values potentially predict mastectomy flap necrosis. Ann Plast Surg. 2013;70:595–8.CrossRef
27.
Zurück zum Zitat Losken A, Styblo TM, Schaefer TG, Carlson GW. The use of fluorescein dye as a predictor of mastectomy skin flap viability following autologous tissue reconstruction. Ann Plast Surg. 2008;61:24–9.CrossRef Losken A, Styblo TM, Schaefer TG, Carlson GW. The use of fluorescein dye as a predictor of mastectomy skin flap viability following autologous tissue reconstruction. Ann Plast Surg. 2008;61:24–9.CrossRef
Metadaten
Titel
Use of Mammographic Measurements to Predict Complications After Nipple-Sparing Mastectomy in BRCA Mutation Carriers
verfasst von
Ko Un Park, MD
Anna Weiss, MD
Kelly Rosso, MD
Min Yi, MD, PhD
Kelly Hunt, MD
Henry Kuerer, MD, PhD
Summer E. Hanson, MD
Rosalind Candelaria, MD
Sarah Tevis, MD
Alastair Thompson, MD
Publikationsdatum
09.08.2019
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 2/2020
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07704-1

Weitere Artikel der Ausgabe 2/2020

Annals of Surgical Oncology 2/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.